VIDAZA 100 mg/1
azacitidine · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Celgene Corporation
No Recall HistoryCurrently in Shortage
Plain English
VIDAZA is a injection, powder, lyophilized, for solution containing azacitidine at 100 mg/1, taken intravenous. Manufactured by Celgene Corporation.
Key Facts
- Brand Name
- VIDAZA
- Generic Name
- azacitidine
- NDC Code (Product)
59572-102- Manufacturer
- Celgene Corporation
- Strength
- 100 mg/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- NDA050794
- Drug Class
- Nucleoside Metabolic Inhibitor [EPC]
- Marketing Start
- 07/05/2004
Recall History
No Recall HistoryFrequently Asked Questions
What is VIDAZA used for?
VIDAZA contains azacitidine. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is VIDAZA a controlled substance?
VIDAZA is not classified as a controlled substance by the DEA.
What is the generic name for VIDAZA?
The generic name for VIDAZA is azacitidine. There are 12 other brand versions of azacitidine.
What is the NDC code for VIDAZA 100 mg/1?
The NDC (National Drug Code) for VIDAZA 100 mg/1 is 59572-102, listed by Celgene Corporation.